Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Rheumatology (Oxford, England)|March 16, 2026
The impact of anti-SSA/Ro antibodies on pregnancy outcomes in patients with systemic lupus erythematosusEriho Yamaguchi, Hideaki Tsuji, Atsubumi Ogawa, et al.
International Journal of Rheumatic Diseases|March 5, 2024
Association of large joint involvement at the start of biological disease-modifying antirheumatic drugs and Janus kinase inhibitors with disease activity and drug retention in patients with rheumatoid arthritis: The ANSWER cohort studyIku Shirasugi, Akira Onishi, Keisuke Nishimura, et al.
Rheumatology (Oxford, England)|October 4, 2023
Trends of disease activity in Japanese patients over 75 years with rheumatoid arthritis from 2014 to 2021: the ANSWER cohort studyHirotaka Yamada, Sadao Jinno, Toshihisa Maeda, et al.
Modern Rheumatology|May 15, 2026
Disentangling Temporal Factors in Organ Damage Accrual in Systemic Lupus Erythematosus: Onset-Age, Onset-Era, and Aging in the Japanese LUNA RegistryRisa Sagawa, Takashi Kida, Akira Onishi, et al.
RMD Open|July 23, 2025
Safety of mycophenolate mofetil in systemic lupus erythematosus maintenance therapy: insights from the LUNA registry in a nationwide prospective cohort studyNaoki Matsuoka, Nobuyuki Yajima, Eisuke Inoue, et al.
Rheumatology (Oxford, England)|November 4, 2023
Real-world comparative study of the efficacy of Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort studyShinya Hayashi, Shotaro Tachibana, Toshihisa Maeda, et al.
Arthritis Research & Therapy|January 8, 2026
Gender differences in the clinical features and quality of life of Japanese patients with systemic lupus erythematosus: a cross-sectional study based on the LUNA registryYuya Sumichika, Honoka Ebina, Shuzo Sato, et al.
Plos One|March 18, 2026
Mode of action-specific and cause-specific retention of biologic and targeted synthetic disease-modifying antirheumatic drugs in anti-SS-A antibody-positive rheumatoid arthritis: The ANSWER cohort studyKazuma Nishisaka, Takaichi Okano, Takumi Imai, et al.
Rheumatology (Oxford, England)|February 6, 2026
Comparison of predictive validity of the Lupus Patient-Reported Outcome and Short-Form-12 for damage accrual in systemic lupus erythematosusAkira Onishi, Hideaki Tsuji, Tsuneo Sasai, et al.
Frontiers in Immunology|May 4, 2026
The relationship between obesity and disease relapse in systemic lupus erythematosus: a retrospective cohort study using the LUNA registryNaoki Suzuki, Ryusuke Yoshimi, Hiroki Mizuno, et al.
Pageof 8